PDL BIOPHARMA INC - NOTE 2.750%12/0

CUSIP: 69329YAG9

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Debt / NOTE 2.750%12/0
Market price (% of par)
105.88%
Total 13F principal
$12,788,008
Principal change
-$55,000
Total reported market value
$13,526,027
Number of holders
7
Value change
-$57,694
Number of buys
1
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 69329YAG9?
CUSIP 69329YAG9 identifies 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PDL BIOPHARMA INC - NOTE 2.750%12/0 as of Q2 2020

As of 30 Jun 2020, PDL BIOPHARMA INC - NOTE 2.750%12/0 was held by 7 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $12,788,008 in principal (par value) of the bond. The largest 7 bondholders included SMH CAPITAL ADVISORS INC, Pinnacle Holdings, LLC, WELLS FARGO & COMPANY/MN, UNITED CAPITAL FINANCIAL ADVISERS, LLC, Archetype Wealth Partners, LLC, ENVESTNET ASSET MANAGEMENT INC, and ADVISOR GROUP HOLDINGS, INC.. This page lists 7 institutional bondholders reporting positions for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.